8 results
10-K
2023 FY
TSBX
Turnstone Biologics Corp
21 Mar 24
Annual report
8:51pm
experiencing a partial response or complete response to any given therapy.
Solid tumors present a major burden to society, with high mortality and poor … tumors contribute a massive burden to society, with high mortality and poor outcomes associated with more advanced disease. In the United States
8-K
EX-99.1
TSBX
Turnstone Biologics Corp
21 Mar 24
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
5:14pm
Presentations at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting Support Ongoing Clinical and Preclinical Efforts. In November 2023
8-K
EX-99.1
TSBX
Turnstone Biologics Corp
5 Mar 24
Regulation FD Disclosure
8:30am
March 2024 1American Cancer Society. Cancer Facts & Figures 2024; 2nd
Turnstone is Pioneering Advancements in Selected TIL Therapy Next-generation … 1American Cancer Society. Cancer Facts & Figures 2024; National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER), accessed March 2024
424B4
TSBX
Turnstone Biologics Corp
21 Jul 23
Prospectus supplement with pricing info
7:14pm
objective response as a patient experiencing a partial response or complete response to any given therapy.
Solid tumors present a major burden to society … present a major burden to society, with high mortality and poor outcomes associated with more advanced disease. Several key factors, such as tumor
S-1/A
nrqdea 8t563m
23 Jun 23
IPO registration (amended)
9:49pm
S-1
ij4btjf yskm53
12 Jun 23
IPO registration
4:28pm
DRS
dy9tow
15 May 23
Draft registration statement
12:00am
- Prev
- 1
- Next